CSI Market
Sign In | Register

Organon and Co (OGN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OGN Annual Cash Flow →
Quarterly cash flow trends provide additional context on Organon and Co's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income254.00
Depreciation & amortization73.00
Amortization of Other Assets93.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset27.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories24.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Business81.00
Share-based Compensation44.00
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Research And Development Asset Acquired Other Than Through Business Combination Fair Value Acquired-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable176.00
Increase (Decrease) in Accounts Payable, Trade106.00
Increase (Decrease) in Accrued Liabilities75.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital67.00
Other Noncash Income (Expense)-17.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-671.00
Discontinued operations0.00
Net Cash flow from Operating Activities332.00
Investing Activities
Capital Expenditures-113.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-10.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses433.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities310.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-32.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-7.00
Other net0.00
Net Financing Transfers-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents574.00
Consideration Paid In Connection With Separation-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-11.00
Net Cash Flow from Financing Activities-50.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow219.00
Total Cash Flow558.00
4 historic quarters locked

Sign in to unlock the full Organon and Co cash flow history.

Sign In Create Free Account

About Organon and Co Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 31, 2026
  • Source: ogn-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-051230

Figures are derived from filed reports and may be restated. Historical data is subject to revision.